Search

Study Shows Some People with Type 1 Diabetes May Be Protected From Complications

Juvenation

Blogs from JDRF and/or Juvenation

JDRF News Blog

The JDRF News Blog discusses the latest research announcements, news stories, and other important events related to type 1 diabetes that have been covered in the media. The blog is written by JDRF staff, and updated once or twice a week. Feedback and c

Study Shows Some People with Type 1 Diabetes May Be Protected From Complications

  • Comments 1

In the 1990's, a groundbreaking study known as the Diabetes Control and Complications Trial (DCCT) showed that, for people with type 1 diabetes, intensive blood sugar control lowers the risk of developing complications.  Specifically, the study showed that tight blood sugar control could reduce the risk of complications anywhere from 40 to 75 percent. 

The DCCT study provided important insight into how the risk of complications may be reduced in people with type 1 diabetes.  However, the DCCT results still don't completely explain why some people with type 1 diabetes develop complications while others don't.  To aid us in solving this puzzle, JDRF helped support research at the Joslin Diabetes Center called the Medalist Study.

The study is an ongoing evaluation of a group of more than 350 people who have lived with type 1 diabetes for more than 50 years (members of Joslin's Medalist Program).  The results of the study, published in the April 2011 issue of the journal Diabetes Care, indicated that a high proportion of the Medalists remained free of complications.  Specifically, about 40 percent were free from eye disease and nerve damage, more than half were free from heart disease, and more than 85 percent were free from kidney disease.

According to the researchers who conducted the study, while many of the Medalists likely didn't develop complications due to good blood sugar control, something else is additionally protecting them.  The study showed that an association may exist between complications and specific combinations of advanced glycosylation end products (AGEs), and also that there are likely additional mechanisms yet to be identified.

JDRF funded this study as part of our research to develop therapies to treat and prevent the complications of type 1 diabetes.  Understanding how and why complications develop is an area of high importance to inform our efforts to attain this goal.  We are looking to the Medalists studies to provide key insight into these efforts.

  • This is what I'm talking about!  I have only some autonomic neuropathy after 35 years of fair control.

    I know inheriting my Mom's low blood pressure genes is one factor, but all of us need to know why.

    Thanks!

Page 1 of 1 (1 items)

ABOUT JUVENATION
Juvenation is a vibrant social network created especially for and by people with type 1 diabetes and their loved ones. More about Juvenation

Terms of Service | Privacy Policy

DONATION
Please consider making a donation to JDRF to support research toward better treatments and a cure for type 1 diabetes.

SUPPORT
For help on Juvenation you can view answers to common support questions or contact us.


JDRF is the worldwide leader for research to prevent, better treat, and ultimately cure type 1 diabetes. It sets the global agenda for diabetes research, and is the largest charitable funder and advocate of diabetes science worldwide. More about JDRF Juvenation is funded through an educational grant from Novo Nordisk through its Changing Diabetes© leadership initiative. More about Novo Nordisk